Drug Discovery and Development Notes

Understanding Drug Development
5,000 Drugs Available in Canada:

  • Includes over-the-counter (OTC) and prescription medications.

  • Less than 1% of drugs originate from plant extracts, demonstrating the limited role of traditional sources compared to synthetic compounds (like aspirin from birch bark).

Prescription Drugs:

  • Typically more potent and subject to more extensive regulation and scrutiny than OTC drugs.

  • Often require a detailed assessment to evaluate their therapeutic effects and adverse reactions before approval.

Pharmaceutical Industry Dynamics

  • Prescription Drug Market is massive (approx. $600 billion/year globally), reflecting high demand for innovative treatments.

  • Drives innovation by recovering costs from new drugs through patent protections that incentivize research and development.

  • The process of drug development is slow, usually taking 8-12 years and costing around $1 billion to bring a drug to market, highlighting the financial and temporal investments needed.

Stages in Drug Development

  1. Discovery Phase:

  • From idea to lead compound (1-3 years), emphasizing thorough research and preliminary assessments.

  • Testing drug candidates for safety and efficacy using cell cultures, often supplemented by computational models predicting interactions and effects.

  1. Development Phase:

  • Includes preclinical work and extensive paperwork (e.g., investigational new drugs or IND applications).

  • Clinical trials last 1-5 years to test safety and effectiveness, involving careful monitoring and data collection to ensure accurate results.

  • Minimum of 5 years typically in reality for drug development, considering delays in approvals and unforeseen challenges.

Lead Compounds to Clinical Candidates

  • Out of 10,000 compounds, only a few progress to clinical trials, showcasing the high dropout rate in drug development.

  • The lead compound undergoes optimization for pharmacokinetics (absorption, distribution, metabolism, and excretion - ADME) and pharmacodynamics (how the drug affects the body).

  • Utilization of synthetic drugs and innovation from various sources (e.g., marine life, which has unique biochemical properties) is increasingly important.

Challenges in Drug Development

  • Transitioning from discovery to clinic (many fail during clinical trials) requires robust planning and strategy.

  • Emphasis on safety testing in small animals, rodents, and larger mammals to gauge effects prior to human trials, ensuring that potential adverse effects are identified early.

Ethical Concerns

  • Animal experimentation necessitates ethical oversight and humane treatment protocols mandated by regulatory agencies.

  • Historical negative outcomes from drugs like thalidomide stress the need for thorough testing and the importance of adhering to ethical standards in research.

Modern Drug Formulation Considerations
Excipient formulation:

  • Must ensure stable, effective drug delivery without adverse effects for consumers, combining various ingredients that enhance drug performance.

  • Formulating for human consumption is key before clinical trials, involving rigorous assessments of drug stability and bioavailability.

Market and Regulatory Factors

  • Upon success in clinical trials, drugs are secured for specific patent durations (20-30 years) to recoup investment and incentivize further research.

  • Comparisons between brand-name and generic equivalents must be understood for patient benefit, as generics offer accessible alternatives that maintain efficacy.

The Drug Approval Process

  • Patients should ask for generic alternatives when available to minimize costs while receiving effective medication.

  • Recalls and counterfeit medications pose significant risks, underscoring the importance of pharmacist oversight and public awareness in medication safety.

Psychological Effects of Drugs

  • Concepts like placebo effect demonstrate that people can experience perceived improvements merely from belief in treatment, highlighting the power of psychology in healthcare.

  • Neurotransmitter interactions:

  • Drugs can affect mood, cognition, and body responses significantly by altering the levels of neurotransmitters such as serotonin, dopamine, and norepinephrine.

Final Thoughts
Cautions with Self-Medication:

  • Risks of using performance enhancers or other drugs should be weighed against medical insights and protocols to avoid harmful consequences.

  • Proper understanding and communication with healthcare providers is crucial for effective treatment plans, ensuring patients are informed and involved in their healthcare decisions.